Lunevia logo

Research Article

70% Liver Resection in Rats. Pentadecapeptide BPC 157 Beneficial Effect Counteracts Worsening Induced by L-NAME

An animal model study where BPC‑157 improved liver recovery metrics and mitigated the worsening effects of nitric oxide synthase inhibition after major hepatic resection in rats.

Study context

Study design
Rodent surgical model with pharmacologic interventions.
Population or model
Rat model of 70% liver resection.
Reported outcomes
Improved liver recovery metrics in treated rats (as reported)

Research question

Does BPC‑157 improve outcomes after extensive liver resection in rats and interact with nitric oxide pathways?

Key findings in the source

BPC‑157 administration was associated with improved liver outcomes and counteraction of L‑NAME‑induced worsening in this rodent model.

Limitations

Animal surgical model; results require validation and clinical translation.

Original source

Sa1612 70% Liver Resection in Rats. Pentadecapeptide BPC 157, L-Arginine, L-NAME: BPC 157 Beneficial Effect Counteracts Worsening Induced by L-NAME

Dalibor Crvenkovic, Marko Sever, Anita Zenko Sever, Ivan Zoricic, Zarko Rasic, Zeljko Romic, Sven Seiwerth, Predrag Sikiric · Gastroenterology · 2016

DOI 10.1016/s0016-5085(16)31202-1animal
Open source record

Related product

Review the complete product page, COAs, specifications, and all approved research sources.

Glow research page

This educational summary helps you review the cited source in context. The third-party article is not reproduced, and the citation does not imply endorsement of a related product.